AstraZeneca will obtain the full rights to Roxadustat in China, FibroGen said, adding that it will retain the US and other ...
Devendra Barlewar, a scientist from the Union Ministry of Defence, successfully underwent his third kidney transplant.
Lack of steady income can cause patients to face difficulties in bearing treatment costs that can reach up to RM40,000 a year ...
AstraZeneca will gain full rights for roxadustat in China where it is approved to treat anaemia seen with chronic kidney ...
Beacon Journal sports writer George M. Thomas details the obstacles on his way to receiving a kidney transplant.
Medical experts reveal the surprising daily behaviors that harm kidney health, from common drinking habits to unexpected ...
The following is a summary of “Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study,” published in the February 2025 issue of BMC Primary Care by ...
Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...